Hugo Ombredane

Hugo Ombredane is a Research Consultant at RIGImmune Inc. since November 2022, focusing on developing LNP-based and nanoemulsion-based nucleic acid delivery vehicles for the human nasal mucosa and coordinating with contract research organizations. As a PhD Researcher at Imperial College London since January 2022, Hugo is engaged in delivering antiviral dsRNA to primary airway epithelium through a nanoemulsion system. Previous roles include Research Associate at Eligo Bioscience, contributing to a CRISPR-based therapy for acne vulgaris, and several positions as a Research Assistant at various institutions, where Hugo conducted extensive research on topics including drug delivery, antimicrobial resistance, and plant biology. Hugo holds an MRes in Biomedical Research from Imperial College London and a BSc in Biological Sciences from the University of East Anglia.